Key players in Treatment-Resistant Depression Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Johnson & Johnson |
jnj.com (opens in a new tab) | 2,376 reports |
| 2 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
| 3 | Otsuka Pharmaceutical Co., Ltd. | — | 231 reports |
| 4 | Axsome Therapeutics | — | 66 reports |
| 5 | Compass Pathways | — | 66 reports |
Also active in Treatment-Resistant Depression Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Aurobindo Pharma |
|
| Motif Neurotech, Inc. |
|
 LivaNova PLC |
|
 Teva Pharmaceutical |
|
 Dr Reddy’s Laboratories |
|
| Cheplapharm | |
| Sciegen Pharmaceuticals | |
 Apotex Inc |
|
| Cadila Healthcare Ltd | |
| Macleods Pharmaceuticals | |
| Pharmazone | |
| Alembic Therapeutics |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Treatment-Resistant Depression Drugs
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Motif Neurotech, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- LivaNova PLC 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Treatment-Resistant Depression Drugs reports by place
One report for each place. Each tile opens that place's report.
Regions 7
Countries 26
Australia report
Brazil report
Canada report
China report
Ecuador report
Egypt report
France report
Germany report
Hong Kong report
India report
Italy report
Japan report
Kenya report
Malaysia report
Mexico report
New Zealand report
Philippines report
Russia report
Saudi Arabia report
Singapore report
South Africa report
Spain report
Thailand report
UAE report
UK report
US report
Compare all 33 places for Treatment-Resistant Depression Drugs, with active trials
Get the full Treatment-Resistant Depression Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.